UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000050779
Receipt number R000057862
Scientific Title A multicenter prospective observational (cohort) study of upper extremity motor activity in patients with stroke to determine the effectiveness of occupational therapy and orthotics in recovering hand and forearm motion.
Date of disclosure of the study information 2023/04/07
Last modified on 2025/04/07 12:23:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A multicenter prospective observational (cohort) study of upper extremity motor activity in patients with stroke to determine the effectiveness of using occupational therapy and bracing in recovering hand and forearm motion.

Acronym

Investigation of upper limb motor activity for the effectiveness of orthotics and intensive occupational therapy to restore hand and forearm motion in patients with stroke.

Scientific Title

A multicenter prospective observational (cohort) study of upper extremity motor activity in patients with stroke to determine the effectiveness of occupational therapy and orthotics in recovering hand and forearm motion.

Scientific Title:Acronym

Investigation of upper limb motor activity for the effectiveness of intensive occupational therapy and orthotics to recovering hand and forearm motion in patients with stroke.

Region

Japan


Condition

Condition

stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the amount of upper limb movement that is recovered in a clinically meaningful way when stroke patients are fitted with upper limb and finger braces and given functional exercises that promote isolated movement. The amount of upper limb movement that achieves clinically meaningful recovery will be examined.

Basic objectives2

Others

Basic objectives -Others

To investigate paraplegic recovery in patients with moderate paraplegia wearing upper extremity and hand orthoses and performing functional exercises that promote isolated movement according to the severity of paraplegia. From the upper extremity motor data and ADLs obtained, we will examine the amount of clinically meaningful functional recovery from upper extremity practice and the amount of upper extremity movement to achieve it.

Trial characteristics_1

Others

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Brunnstrom recovery stage
Fugl meyer assessment
Wolf Motor Function Test
Action Research Arm Test

Key secondary outcomes

EuroQual
Jikei Assessment Scale for Motor Impairment in Daily Living
Functional Independence Measure


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1.Stroke patients with upper extremity paralysis aged 18 to 90.
2. Less than 6 months after stroke onset.
3. Patients with upper limb Brunnstrom stage III-IV, which is an evaluation of upper limb function.
4. Those who are in stable general condition.
5. Able to understand the research plan without cognitive impairment.
6. Patients who have been fully informed about the study and who have given written consent of their own free will based on a thorough understanding of the study.
7. Gender is not an issue.
8. The training will be limited to those who are able to follow the research implementation schedule.

Key exclusion criteria

1. Those who have fragile skin and cannot wear braces or wristwatch type activity loggers.
2. Patients with mentally anxious.
3.In addition, those who are judged inappropriate for participation in this research by the person responsible for the research(co-investigator).
4.Those who have a disease that is not stable or requires urgent treatment (acute heart failure, acute renal failure, acute liver failure, severe diabetes, infectious disease, etc.)
5.Those who have participated in other clinical trials within 4 months
6.Those who have dementia and cannot train as instructed.
7. Those who cannot perform training as instructed due to higher brain dysfunction

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Naoto
Middle name
Last name Ohtaki

Organization

Izumi Memorial Hospital

Division name

Department of Rehabilitation

Zip code

123-0853

Address

1-3-7 Motoki,Adachi Ward, Tokyo

TEL

+81-03-5888-2111

Email

ot.naoto@gmail.com


Public contact

Name of contact person

1st name Naoto
Middle name
Last name Ohtaki

Organization

Izumi Memorial Hospital

Division name

Department of Rehabilitation

Zip code

123-0853

Address

1-3-7 Motoki,Adachi,Tokyo

TEL

+81-03-5888-2111

Homepage URL


Email

ot.naoto@gmail.com


Sponsor or person

Institute

Izumi Memorial Hospital

Institute

Department

Personal name

Naoto Ohtaki


Funding Source

Organization

Izumi Memorial Hospital

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

Graduate School of Health Science Saitama Prefectural University

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Social Medical Corporation Izenkai Ethics Revie Committee for observational studies

Address

1-3-7 Motoki,Adachi,Tokyo

Tel

+81-03-5888-2111

Email

ot.naoto@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 04 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2023 Year 03 Month 01 Day

Date of IRB

2023 Year 03 Month 30 Day

Anticipated trial start date

2023 Year 04 Month 01 Day

Last follow-up date

2026 Year 12 Month 31 Day

Date of closure to data entry

2027 Year 12 Month 31 Day

Date trial data considered complete

2027 Year 12 Month 31 Day

Date analysis concluded

2027 Year 12 Month 31 Day


Other

Other related information

NO


Management information

Registered date

2023 Year 04 Month 06 Day

Last modified on

2025 Year 04 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000057862